THE DEAL, AT A GLANCE
From the announcementOna Therapeutics
01Who is involvedBacked by Columbus Venture Partners, Mérieux Equity PartnersFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedOna Therapeutics raised $86.6M Series B, announced 2026-06-04From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersOna Therapeutics' $86.6M Series B is a mid-pack Healthcare & Life Sciences financing that aligns with active sector capital flow rather than an outlier round-size signal.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Ona Therapeutics · Financing Record
Explore source-linked visual explanations for Ona Therapeutics. Unsupported claims are withheld while source review continues.
Record 5424 · Recorded date: 2026-06-04
Explore company records →